Continuation Study of the Oral AKT Inhibitor GSK2110183
Clinical trial NCT01531894 · COMPLETED
Trial details
- NCT number
- NCT01531894
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-08
- Primary completion
- 2018-06-20
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.